4.5 Article

Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: Importance of emotions score in atopic dermatitis

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate

Jon I. Williams et al.

CURRENT MEDICAL RESEARCH AND OPINION (2010)

Article Dermatology

Itch characteristics in atopic dermatitis: results of a web-based questionnaire

A. Dawn et al.

BRITISH JOURNAL OF DERMATOLOGY (2009)

Article Dermatology

Arabic version of Skindex-16: Translation and cultural adaptation, with assessment of reliability and validity

Khalid M. AlGhamdi et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)

Article Dermatology

Effect of standard medication on quality of life of patients with atopic dermatitis

Makoto Kawashima et al.

JOURNAL OF DERMATOLOGY (2007)

Article Dermatology

Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis

Tamihiro Kawakami et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2006)

Letter Dermatology

Bepotastine besilate rapidly inhibits miteantigen induced immediate reactions in atopic dermatitis

T Nakahara et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2003)

Review Dermatology

Pathophysiology of pruritus in atopic dermatitis:: an overview

S Ständer et al.

EXPERIMENTAL DERMATOLOGY (2002)

Review Dermatology

Systemic therapy of atopic dermatitis

R Sidbury et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2000)